In VitroActivity of Rifampin, Rifabutin, Rifapentine, and Rifaximin against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection

MLA

Albano, Mariana, et al. “In VitroActivity of Rifampin, Rifabutin, Rifapentine, and Rifaximin against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection.” Antimicrobial Agents and Chemotherapy, vol. 63, no. 11, Aug. 2019. EBSCOhost, https://doi.org/10.1128/AAC.00959-19.

APA

Albano, M., Karau, M. J., Greenwood-Quaintance, K. E., Osmon, D. R., Oravec, C. P., Berry, D. J., Abdel, M. P., & Patel, R. (2019). In VitroActivity of Rifampin, Rifabutin, Rifapentine, and Rifaximin against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection. Antimicrobial Agents and Chemotherapy, 63(11). https://doi.org/10.1128/AAC.00959-19

Chicago

Albano, Mariana, Melissa J. Karau, Kerryl E. Greenwood-Quaintance, Douglas R. Osmon, Caitlin P. Oravec, Daniel J. Berry, Matthew P. Abdel, and Robin Patel. 2019. “In VitroActivity of Rifampin, Rifabutin, Rifapentine, and Rifaximin against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection.” Antimicrobial Agents and Chemotherapy 63 (11). doi:10.1128/AAC.00959-19.